Added to YB: 2024-08-28
Pitch date: 2024-06-30
ZEAL.CO [bullish]
Zealand Pharma A/S
-57.93%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
Market Cap
DKK 30.0B
Pitch Price
DKK 910.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
2.01
P/E
4.65
EV/Sales
1.56
Sector
Biotechnology
Category
growth
Show full summary:
Franklin Biotechnology Discovery Fund New Position: Zealand Pharma A/S
ZEAL.CO: Biotech's petrelintide shows promise in weight loss, potential GLP-1 competitor. Phase 1B data positive for efficacy & tolerability. Possible synergy with survodutide. Phase 2 study starting 2024, data expected H1 2026. Share price surged on news.
Read full article (1 min)